IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise.
IQVIA supports clinical development across the research lifecycle, from early phase studies through late phase clinical trials and post marketing research, enabled by integrated data, technology and analytics capabilities. IQVIA also delivers real world evidence and commercialization solutions that help healthcare stakeholders understand the value, safety, and use of medicines in clinical practice. IQVIA works with a broad range of organizations, including emerging biotechnology companies and large pharmaceutical organizations, supporting clinical research in local markets while enabling access to global expertise, data, and technologies across regions. These services are provided globally, including support for clinical research activities in Australia and New Zealand.
Service offerings:
- Clinical Development Consultancy
- Regulatory Access Consultancy
- Clinical Research Services
- Real World Evidence and Observational Research
- Data, Technology, and Advanced Analytics
Therapeutic areas include (but are not limited to):
Oncology and Hematology; Cell and Gene Therapy (CGT); Rare Diseases and Orphan Indications; Infectious Diseases and Vaccines; Neurology and Central Nervous System Disorders (CNS); Psychiatry and Mental Health; Cardiovascular Diseases (CVD); Metabolic and Endocrine Disorders, including Diabetes and Obesity (MET/ENDO); Immunology and Inflammatory Diseases; Respiratory Diseases; Gastroenterology and Hepatology (GI/HEP); Nephrology and Urology; Women’s Health and Reproductive Medicine; Pediatrics and Neonatology; Dermatology; Ophthalmology; Musculoskeletal and Rheumatologic Disorders; and Medical Devices and Combination Products.